| Glycoprotein non-metastatic melanoma protein B (GPNMB) and cancer: a novel potential therapeutic target M Taya, SR Hammes Steroids 133, 102-107, 2018 | 80 | 2018 |
| Estrogen maintains myometrial tumors in a lymphangioleiomyomatosis model H Prizant, M Taya, I Lerman, A Light, A Sen, S Mitra, TH Foster, ... Endocrine-related cancer 23 (4), 265-280, 2016 | 37 | 2016 |
| Neutrophil elastase from myeloid cells promotes TSC2-null tumor growth M Taya, M de la Luz Garcia-Hernandez, J Rangel-Moreno, B Minor, ... Endocrine-related cancer 27 (4), 261-274, 2020 | 17 | 2020 |
| Paxillin and embryonic PolyAdenylation Binding Protein (ePABP) engage to regulate androgen-dependent Xenopus laevis oocyte maturation-A model of kinase-dependent regulation of … SU Miedlich, M Taya, MR Young, SR Hammes Molecular and cellular endocrinology 448, 87-97, 2017 | 9 | 2017 |
| Prolactin is expressed in uterine leiomyomas and promotes signaling and fibrosis in myometrial cells A DiMauro, C Seger, B Minor, AM Amitrano, I Okeke, M Taya, AR Rackow, ... Reproductive Sciences, 1-11, 2021 | 7 | 2021 |
| Estradiol augments tumor-induced neutrophil production to promote tumor cell actions in lymphangioleiomyomatosis models BMN Minor, D LeMoine, C Seger, E Gibbons, J Koudouovoh, M Taya, ... Endocrinology 164 (6), bqad061, 2023 | 5 | 2023 |
| Glucocorticoid Receptor Activation in Lobular Breast Cancer Is Associated with Reduced Cell Proliferation and Promotion of Metastases BA Porter, C Frerich, M Lainé, AB Clark, I Durdana, J Lee, M Taya, ... Cancers 15 (19), 4679, 2023 | 4 | 2023 |
| SAT-003 prolactin is expressed in uterine leiomyomas and may promote their growth AR DiMauro, A Dahal, I Okeke, I Lerman, A Amitrano, C Seger, D Kumar, ... Journal of the Endocrine Society 4 (Supplement_1), SAT-003, 2020 | 1 | 2020 |
| Glycoprotein non-metastatic melanoma protein B promotes tumor growth and is a biomarker for lymphangioleiomyomatosis E Gibbons, M Taya, H Wu, SH Lopa, J Moss, EP Henske, FX McCormack, ... Endocrine-related cancer 31 (6), 2024 | | 2024 |
| THU475 Ovarian Tumor-cell Glucocorticoid Receptor Activity Modulates Cytokine Secretion Promoting Recruitment And Activation of Immunosuppressive Cells Into The Tumor … M Taya, E LeBlanc, L Bennett, SD Conzen Journal of the Endocrine Society 7 (Supplement_1), bvad114. 2103, 2023 | | 2023 |
| THU551 Glycoprotein-NMB (GPNMB) Is A Potential Lymphangioleiomyomatosis (LAM) Therapeutic Target And Biomarker E Gibbons, M Taya, H Wu, FX McCormack, SR Hammes Journal of the Endocrine Society 7 (Supplement_1), bvad114. 2177, 2023 | | 2023 |
| Ovarian cancer-cell glucocorticoid receptor activity modulates cytokine secretion promoting infiltration of immunosuppressive cells into the tumor microenvironment M Taya, E LeBlanc, L Bennett, SD Conzen Cancer Research 83 (7_Supplement), 654-654, 2023 | | 2023 |
| 225P Ovarian cancer-cell glucocorticoid receptor activity modulates cytokine secretion promoting infiltration of immunosuppressive cells into the tumor microenvironment M Taya, L Bennett, SD Conzen Immuno-Oncology and Technology 16, 2022 | | 2022 |
| OR22-6 Ovarian Cancer Cell Glucocorticoid Receptor Activity Is Associated With Cytokine Secretion Promoting Infiltration of Immunosuppressive Cells Into the Tumor Microenvironment M Taya Journal of the Endocrine Society 6 (Suppl 1), A457, 2022 | | 2022 |
| RF19| PSUN351 Glycoprotein-NMB (GPNMB) is Pro-Tumorigenic in Lymphangioleiomyomatosis (LAM) E Gibbons, S Hammes, M Taya Journal of the Endocrine Society 6 (Supplement_1), A898-A898, 2022 | | 2022 |
| Ovarian cancer cell glucocorticoid receptor activity is associated with cytokine secretion promoting infiltration of immunosuppressive cells into the tumor microenvironment M Taya, J Gonzalez, L Bennett, SD Conzen Cancer Research 82 (12_Supplement), 1335-1335, 2022 | | 2022 |
| Glycoprotein-NMB (GPNMB) is Pro-Tumorigenic in Lymphangioleiomyomatosis (LAM) E Gibbons, M Taya, S Hammes The Journal of Immunology 208 (1_Supplement), 178.16-178.16, 2022 | | 2022 |
| SAT-141 Glycoprotein NMB (GPNMB) Is Pro-Tumorigenic in TSC2-Null Cancer Cells and Is a Potential Drug Target and Biomarker for Lymphangioleiomyomatosis (LAM) E Gibbons, M Taya, C Seger, SR Hammes Journal of the Endocrine Society 4 (Supplement_1), SAT-141, 2020 | | 2020 |
| Neutrophil Elastase and GPNMB as Novel Potential Therapeutic Targets in a Tsc2-null Mouse Model for Lymphangioleiomyomatosis (LAM) Tumor Growth M Taya University of Rochester, 2020 | | 2020 |
| OR34-5 Infiltrating Neutrophils and Neutrophil Elastase (NE) Promote Tumor Growth in a Mouse Model for Lymphangioleiomyomatosis (LAM) M Taya, M Garcia-Hernandez, J Rangel-Moreno, H Prizant, S Hammes Journal of the Endocrine Society 3 (Supplement_1), OR34-5, 2019 | | 2019 |
